[MM] Jay Park's Zgoo Holdings, Founder of Socar, Bets on Noul at Twice the Share Price
Predicted impact: Medium
Zgoo's Noul investment at twice share price; rights offering already reported, only ₩2.8B in size.
Zgoo Holdings지구홀딩스
221800 · KOSDAQ · ₩221800 · 지구홀딩스
₩3,600▼ ₩70 (1.91%)End-of-day · Oct 27, 2026 · End-of-day prices.
Price · 1Y +7.14%
- Market cap
- ₩59B
- Enterprise value
- ₩43B
- P/E
- —
- P/B
- 1.0×
- Dividend yield
- 2.8%
- ROE
- −9.4%
- Net margin
- −16.8%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−89.0% from the high
₩3,310Today: ₩3,375 – ₩3,670₩32,800
Returns
- 1W−0.4%
- 1M−0.7%
- 3M−14.6%
- 6M−81.5%
- YTD−8.2%
- 1Y+7.1%
- Volume today
- 19,947
- 0.9× the 20-day average
- Traded today
- ₩71M
- Listed shares
- 16,318,851
- EPS (12 months)
- −₩331
- Earnings yield −9.2%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 42 of 100 (50 is a normal day for this stock).
- SentimentPositiveNews: Reports point to rising deal expectations, but the sources do not give details of any confirmed deal. Community: 0 bullish, 0 bearish posts this week.
- MomentumFlat2.6% over the last month; the price is below its 20-day average.
- News impactSome3 news items and filings in two weeks; 0 rated high impact, 3 medium.
Signals describe activity, not recommendations. Not financial advice.
Zgoo Holdings stock overview
Zgoo Holdings (지구홀딩스, KRX: 221800) is listed on KOSDAQ, in the Engineering services sector. The company operates two main business lines: in vitro diagnostic testing services, which include general diagnostic tests and molecular diagnostic tests, and medical IT solutions, such as health checkup software, EMR-linked software, PHR services, and cloud services. Its shares closed at ₩3,600 on Oct 27, 2026, down 1.91% on the day, giving it a market value of ₩59B.
Key facts
- Market cap
- ₩59B
- Sector
- Engineering services
- Latest price change
- −1.91%
- As of
- Oct 27, 2026
- Main business
- The company operates two main business lines: in vitro diagnostic testing services, which include general diagnostic tests and molecular diagnostic tests, and medical IT solutions, such as health checkup software, EMR-linked software, PHR services, and cloud services.
Quick answers about Zgoo Holdings
- What does Zgoo Holdings do?
- The company operates two main business lines: in vitro diagnostic testing services, which include general diagnostic tests and molecular diagnostic tests, and medical IT solutions, such as health checkup software, EMR-linked software, PHR services, and cloud services. It collects blood and urine samples from hospitals and clinics through one direct store and 19 agencies nationwide, has partner medical institutions analyze them, and delivers results to healthcare providers through its software. It is also pursuing new businesses including clinical trial services and personalized gut microbiome health management.
- What is the market cap of Zgoo Holdings?
- The market capitalisation of Zgoo Holdings was ₩59B at the close on Oct 27, 2026.
- Who are the largest shareholders of Zgoo Holdings?
- According to the latest official filings, the largest reported holders are Lee Jae-ung (20.36%, as of Jul 3, 2026); Kim Jin-tae (15.38%, as of Jan 6, 2026); Daewoong (14.99%, as of Jan 22, 2026).
- When is the next earnings report from Zgoo Holdings?
- Korean companies rarely announce results dates in advance. Based on when Zgoo Holdings filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Company profile
The company operates two main business lines: in vitro diagnostic testing services, which include general diagnostic tests and molecular diagnostic tests, and medical IT solutions, such as health checkup software, EMR-linked software, PHR services, and cloud services. It collects blood and urine samples from hospitals and clinics through one direct store and 19 agencies nationwide, has partner medical institutions analyze them, and delivers results to healthcare providers through its software. It is also pursuing new businesses including clinical trial services and personalized gut microbiome health management.
Written by AI from the company's latest annual report.
- Korean name
- 지구홀딩스
- Sector
- Engineering services
- Themes
- —
- CEO
- 이재웅
- Founded
- Jan 2009
- Listed
- Nov 2023
- Listed shares
- 16,318,851
- Fiscal year ends
- Month 12
- Website
- www.zgoo.xyz
Similar companies
- Samsung E&A028050 · ₩12T₩62,200+4.01%
- HD Hyundai Marine Solution443060 · ₩7.9T₩176,700+4.19%
- KEPCO Engineering & Construction052690 · ₩3.5T₩91,600+0.44%
- POSCO DX022100 · ₩2.9T₩19,050+2.36%
- Hanyang ENG045100 · ₩476B₩27,200+2.45%
- SemiFive490470 · ₩467B₩13,720+5.54%
- Korea Electronic Power Industrial Development130660 · ₩330B₩10,130+1.50%
- HanmiGlobal053690 · ₩195B₩17,840+2.88%
Recent news
Noul starts with two limit-up days, expectations rise for Zgoo Holdings acquisition by Socar's Lee Jae-woong
Predicted impact: Medium
Rights offering of 2.8B won is small; acquisition speculation about Zgoo adds moderate interest.
Noul Announces ₩2.8B Rights Offering, Third-Party Allotment to Zgoo Holdings Co., Ltd.
Predicted impact: Medium
Third-party rights offering of about 2.8B won, roughly 5% of market value.
Recent filings
See all- Amended: Half-year report (Jun 2026)Oct 1, 2026
- Added attachment: Half-year report (Jun 2026)Aug 28, 2026
- Change of CEOAug 27, 2026
- Preliminary earnings (consolidated)Aug 19, 2026
- Investor relations (IR) eventAug 13, 2026
Titles in Korean until English translations are added.
Also known as: Zgoo Holdings / 지구홀딩스 / 221800 / KRX:221800
Source: KRX statistical information